The post Galaxy One Opens for Business appeared on BitcoinEthereumNews.com. Shares of Galaxy Digital rose 8% in premarket trading Monday as the company rolled out GalaxyOne, a mobile and web platform built to give retail investors access to a blend of cash, crypto, and equity investing tools, with yield at the core. The app gives users access to FDIC-insured high-yield cash accounts, crypto trading, and U.S. equities and exchange-traded funds (ETFs), the company announced in a press release. Galaxy says it’s offering 4% annual returns on regular cash deposits and up to 8% for accredited investors through its Galaxy Premium Yield product. Both rates are powered by the company’s institutional lending business, which manages a loan book of more than $1.1 billion. Beyond passive yield, GalaxyOne users can trade across digital assets like bitcoin BTC$125,237.45, ether ETH$4,693.75 and solana SOL$236.28, as well as stocks listed on major U.S. exchanges. Galaxy also offers automated reinvestment of earnings into crypto or cash, aiming to simplify compounding returns, the company said. The launch puts Galaxy in direct competition with Robinhood (HOOD) and Coinbase (COIN), two of the dominant players among digital-first retail traders in the U.S. Both have launched new services this year — including crypto staking, margin trading and retirement accounts — as they try to lock in more users and increase assets held on their platforms. HOOD and COIN are both trading about 2% higher in pre-market trading alongside a general rise in stock and crypto markets. Galaxy’s move is notable in part because of its institutional background. The company went public on Nasdaq in May and its stock is up 100% since the listing. Originally built on the infrastructure of Fierce, a fintech platform Galaxy acquired last year, GalaxyOne signals a broader push into consumer finance from a firm historically focused on institutional clients. Galaxy said more features are on… The post Galaxy One Opens for Business appeared on BitcoinEthereumNews.com. Shares of Galaxy Digital rose 8% in premarket trading Monday as the company rolled out GalaxyOne, a mobile and web platform built to give retail investors access to a blend of cash, crypto, and equity investing tools, with yield at the core. The app gives users access to FDIC-insured high-yield cash accounts, crypto trading, and U.S. equities and exchange-traded funds (ETFs), the company announced in a press release. Galaxy says it’s offering 4% annual returns on regular cash deposits and up to 8% for accredited investors through its Galaxy Premium Yield product. Both rates are powered by the company’s institutional lending business, which manages a loan book of more than $1.1 billion. Beyond passive yield, GalaxyOne users can trade across digital assets like bitcoin BTC$125,237.45, ether ETH$4,693.75 and solana SOL$236.28, as well as stocks listed on major U.S. exchanges. Galaxy also offers automated reinvestment of earnings into crypto or cash, aiming to simplify compounding returns, the company said. The launch puts Galaxy in direct competition with Robinhood (HOOD) and Coinbase (COIN), two of the dominant players among digital-first retail traders in the U.S. Both have launched new services this year — including crypto staking, margin trading and retirement accounts — as they try to lock in more users and increase assets held on their platforms. HOOD and COIN are both trading about 2% higher in pre-market trading alongside a general rise in stock and crypto markets. Galaxy’s move is notable in part because of its institutional background. The company went public on Nasdaq in May and its stock is up 100% since the listing. Originally built on the infrastructure of Fierce, a fintech platform Galaxy acquired last year, GalaxyOne signals a broader push into consumer finance from a firm historically focused on institutional clients. Galaxy said more features are on…

Galaxy One Opens for Business

Shares of Galaxy Digital rose 8% in premarket trading Monday as the company rolled out GalaxyOne, a mobile and web platform built to give retail investors access to a blend of cash, crypto, and equity investing tools, with yield at the core.

The app gives users access to FDIC-insured high-yield cash accounts, crypto trading, and U.S. equities and exchange-traded funds (ETFs), the company announced in a press release. Galaxy says it’s offering 4% annual returns on regular cash deposits and up to 8% for accredited investors through its Galaxy Premium Yield product. Both rates are powered by the company’s institutional lending business, which manages a loan book of more than $1.1 billion.

Beyond passive yield, GalaxyOne users can trade across digital assets like bitcoin BTC$125,237.45, ether ETH$4,693.75 and solana SOL$236.28, as well as stocks listed on major U.S. exchanges. Galaxy also offers automated reinvestment of earnings into crypto or cash, aiming to simplify compounding returns, the company said.

The launch puts Galaxy in direct competition with Robinhood (HOOD) and Coinbase (COIN), two of the dominant players among digital-first retail traders in the U.S. Both have launched new services this year — including crypto staking, margin trading and retirement accounts — as they try to lock in more users and increase assets held on their platforms.

HOOD and COIN are both trading about 2% higher in pre-market trading alongside a general rise in stock and crypto markets.

Galaxy’s move is notable in part because of its institutional background. The company went public on Nasdaq in May and its stock is up 100% since the listing. Originally built on the infrastructure of Fierce, a fintech platform Galaxy acquired last year, GalaxyOne signals a broader push into consumer finance from a firm historically focused on institutional clients.

Galaxy said more features are on the way, including business accounts, crypto staking and expanded lending products.

Source: https://www.coindesk.com/markets/2025/10/06/galaxy-takes-on-robinhood-coinbase-with-4-yield-app-stock-jumps-8

Market Opportunity
Oasis Logo
Oasis Price(ROSE)
$0.01316
$0.01316$0.01316
-3.80%
USD
Oasis (ROSE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26